Identifying the Cellular Target of Cordyheptapeptide A and Synthetic Derivatives-Reference-Cited by-同舟云学术

Identifying the Cellular Target of Cordyheptapeptide A and Synthetic Derivatives

Published:2021-07-12 Issue:8 Volume:16 Page:1354-1364
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Klein Victoria G.¹^ORCID,Bray Walter M.¹,Wang Hao-Yuan²,Edmondson Quinn¹,Schwochert Joshua¹,Ono Satoshi³^ORCID,Naylor Matthew R.¹,Turmon Alexandra C.¹,Faris Justin H.¹,Okada Okimasa³,Taunton Jack²^ORCID,Lokey R. Scott¹^ORCID

Affiliation:

1. Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, United States

2. Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, 94158, United States

3. Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa 227-0033, Japan

Funder

National Center for Research Resources

Division of Graduate Education

University of California

National Institute of General Medical Sciences

Eli Lilly and Company

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.1c00094

Reference58 articles.

1. Form and Function in Cyclic Peptide Natural Products: A Pharmacokinetic Perspective

2. Cyclic peptide therapeutics: past, present and future

3. Retrospective analysis of natural products provides insights for future discovery trends

4. Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery

5. The exploration of macrocycles for drug discovery — an underexploited structural class

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of Acinetobacter sp. RIT 592 induces the production of broad-spectrum antibiotics in Exiguobacterium sp. RIT 594;Frontiers in Pharmacology;2024-08-01

2. The eEF1A protein in cancer: Clinical significance, oncogenic mechanisms, and targeted therapeutic strategies;Pharmacological Research;2024-06

3. Recent developments in the total synthesis of natural products using the Ugi multicomponent reactions as the key strategy;Organic & Biomolecular Chemistry;2024

4. Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art;International Journal of Molecular Sciences;2023-03-08

5. Site-directed late-stage diversification of macrocyclic nannocystins facilitating anticancer SAR and mode of action studies;RSC Medicinal Chemistry;2023